| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 791 | 0.00 USD | |
| 12 Dec 2025 | OTHER | Merus N.V. | 6,120 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 17,262 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 16,604 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 14,414 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 8,844 | 0.00 USD | deriv |
| 12 Dec 2025 | OTHER | Merus N.V. | 13,193 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Merus N.V. | 13,193 | 0.00 USD | deriv |
| 06 May 2025 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 1,071 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 07 May 2024 | GRANT_AWARD | Merus N.V. | 8,844 | 0.00 USD | deriv |
| 23 Apr 2024 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 564 | 0.00 USD | |
| 01 Apr 2024 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Merus N.V. | 14,414 | 0.00 USD | deriv |
| 25 Apr 2023 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 616 | — | |
| 01 Apr 2023 | GRANT_AWARD | Replimune Group, Inc. | 25,200 | 0.00 USD | deriv |
| 31 May 2022 | GRANT_AWARD | Merus N.V. | 16,604 | 0.00 USD | deriv |
| 24 May 2022 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 632 | — | |
| 01 Apr 2022 | GRANT_AWARD | Replimune Group, Inc. | 16,500 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 67,000 | 0.00 USD | deriv |
| 28 May 2021 | GRANT_AWARD | Merus N.V. | 6,120 | 0.00 USD | deriv |
| 04 May 2021 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 577 | — | |
| 01 Apr 2021 | GRANT_AWARD | Replimune Group, Inc. | 16,500 | 0.00 USD | deriv |
| 30 Jun 2020 | GRANT_AWARD | Merus N.V. | 17,262 | 0.00 USD | deriv |
| 05 May 2020 | GRANT_AWARD | WEST PHARMACEUTICAL SERVICES INC | 975 | — |
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Replimune Group, Inc. | 32,000 | reported | 01 Apr 2025 | tx 6+155,200 |
| NEWLINK GENETICS CORP | 27,777 | reported | 23 May 2018 | tx 4+63,642 |
| WEST PHARMACEUTICAL SERVICES INC | 11,854.297 | reported | 04 May 2026 | tx 12+11,645.03 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 1−67,000 |
| DYAX CORP | 0 | reported | 22 Jan 2016 | tx 10+250,000−250,000 |
| Merus N.V. | 0 | reported | 12 Dec 2025 | tx 12+76,437−76,437 |
| ARQULE INC | 0 | reported | 16 Jan 2020 | tx 78+6,827,871−7,214,587 |
4 purchases reported after at least 12 months of silence — most recent on 24 Aug 2017.